Kenvue Inc.
$17.81
-$0.06 (-0.34%)
$17.76Day Range$17.97
Key Statistics
Market Cap
$34.21B
Shares Outstanding
1,920.8M
Primary Exchange
XNYS
Currency
USD
Type
CS
IPO Date
May 4, 2023
Round Lot
100
Locale
US
Trading Data
Day Open
$17.80
Day High
$17.97
Day Low
$17.76
Volume
26.72M
VWAP
$17.84
Prev Close
$17.87
Transactions
--
Acc. Volume
--
About Kenvue Inc.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
PERFUMES, COSMETICS & OTHER TOILET PREPARATIONSSIC 284422,000 employees1 KENVUE WAY, SUMMIT, NJ, 07901908-874-1200IPO May 4, 2023US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001944048
- Composite FIGI
- BBG01C79X561
- Share Class FIGI
- BBG01C79X614
- Ticker Root
- KVUE
- SIC Code
- 2844
About Kenvue Inc. (KVUE) Stock
Kenvue Inc. (KVUE) closed the 2026-09-18 session at $17.81, down 0.34% versus the previous close (-0.06). The stock opened at $17.80 and traded between $17.76 and $17.97 during that session. Session trading volume was 26.7M shares. The volume-weighted average price (VWAP) is $17.84.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
Kenvue Inc. has a market capitalization of $34.21 billion. The company operates in the PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS industry classification. KVUE is listed on the XNYS exchange. The company employs approximately 22,000 people. Kenvue Inc. is headquartered in SUMMIT, NJ. The recorded listing date is 2023-05-04.
On this page you can find market KVUE stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS sector.